{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-043270","form_type":"8-K","ticker":"INMB","cik":"0001711754","company_name":"Inmune Bio, Inc.","filed_at":"2025-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.430486+00:00","generated_at":"2026-05-21T09:02:38.452879+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"INmune Bio to present at RBC Capital Markets Global Healthcare Conference on May 20-21","bullets":["Fireside chat and 1-on-1 virtual meetings on May 20-21, 2025, at InterContinental Barclay NY.","Presentation at 11:00am EDT; no material financial or pipeline updates announced.","Clinical-stage biotech targeting innate immune system with three product platforms.","No new clinical data, partnerships, or financial disclosures in the release."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-043270","json":"https://secwatch.observer/filing/0001213900-25-043270.json","markdown":"https://secwatch.observer/filing/0001213900-25-043270.md","text":"https://secwatch.observer/filing/0001213900-25-043270.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711754/000121390025043270/0001213900-25-043270-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711754/000121390025043270/ea0242053-8k_inmune.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T09:02:38.452879+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}